Physical therapists should play a greater role in managing patients with opioid use and opioid misuse.
Physical therapy
chronic opioid use
opioid misuse
opioid use disorder
physical therapist
Journal
Substance abuse
ISSN: 1547-0164
Titre abrégé: Subst Abus
Pays: United States
ID NLM: 8808537
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
16
9
2021
medline:
15
3
2022
entrez:
15
9
2021
Statut:
ppublish
Résumé
The U.S. opioid crisis necessitates that health care providers of all types work collaboratively to manage patients taking prescription opioid medications and manage those who may be misusing prescription opioids. Musculoskeletal conditions are the most common diagnoses associated with an opioid prescription. Physical therapists commonly manage patients with musculoskeletal conditions and chronic pain. Some patients who attend physical therapy for pain management take prescription opioid medications for pain and some of these patients may be misusing prescription opioids. Physical therapists who manage patients with musculoskeletal conditions are well-positioned to help address the opioid crisis. Historically, physical therapists have not been adequately engaged in efforts to manage persons with co-occurring musculoskeletal pain and opioid misuse or OUD. The American Physical Therapy Association (APTA) has emphasized physical therapy over the use of prescription opioids for the management of painful conditions. The APTA, however, does not highlight the important role that physical therapists could play in monitoring opioid use among patients receiving treatment for pain, nor the role that physical therapists should play in screening for opioid misuse. Such screening could facilitate referral of patients suspected misuse to an appropriate provider for formal assessment and treatment. This commentary presents simulated musculoskeletal patient presentations depicting 2 common opioid use states; chronic opioid use and opioid misuse. The cases highlight and interactions that physical therapists could have with these patients and actions that the physical therapist could take when working inter-disciplinarily. Recommendations are provided that aim to increase physical therapists' knowledge and skills related to managing patients taking prescription opioid medications for pain.
Identifiants
pubmed: 34524070
doi: 10.1080/08897077.2021.1971818
pmc: PMC8576962
mid: NIHMS1748827
doi:
Substances chimiques
Analgesics, Opioid
0
Prescription Drugs
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
255-260Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR002539
Pays : United States
Organisme : NIDA NIH HHS
ID : UG1 DA049444
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States
Références
Pain Med. 2008 May-Jun;9(4):444-59
pubmed: 18489635
Am J Ind Med. 2021 Jan;64(1):48-57
pubmed: 33231876
J Pain. 2020 Jul - Aug;21(7-8):869-880
pubmed: 31837448
Subst Abus. 2019;40(4):405-411
pubmed: 31774387
N Engl J Med. 2014 May 29;370(22):2063-6
pubmed: 24758595
JAMA Netw Open. 2019 Dec 2;2(12):e1917228
pubmed: 31825504
JAMA. 2021 Jul 13;326(2):154-164
pubmed: 34255008
Ann Intern Med. 2017 Sep 5;167(5):293-301
pubmed: 28761945
Phys Ther. 2018 Dec 1;98(12):990-999
pubmed: 30260429
Pain. 2010 Aug;150(2):332-339
pubmed: 20554392
BMC Health Serv Res. 2015 Apr 09;15:150
pubmed: 25880898
Phys Ther. 2011 Mar;91(3):330-45
pubmed: 21233306
Subst Abus. 2021 Jul 20;:1-9
pubmed: 34283690
Subst Abus. 2019;40(4):421-434
pubmed: 31809680
JAMA. 2020 Mar 3;323(9):863-884
pubmed: 32125402
Semin Arthritis Rheum. 2016 Dec;46(3):259-260
pubmed: 27519477
Exp Clin Psychopharmacol. 2008 Oct;16(5):429-34
pubmed: 18837639
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
Subst Abus. 2019;40(4):412-420
pubmed: 31638876
Health Serv Res. 2018 Dec;53(6):4629-4646
pubmed: 29790166
Public Health Rev. 2014 Jan;35(2):
pubmed: 26568649
Ann Rheum Dis. 2019 Jun;78(6):844-848
pubmed: 30987966
J Subst Abuse Treat. 2017 Jun;77:26-30
pubmed: 28476267
J Eval Clin Pract. 2016 Apr;22(2):247-52
pubmed: 26417660
J Orthop Sports Phys Ther. 2018 May;48(5):349-353
pubmed: 29712547
J Pain. 2017 Apr;18(4):437-445
pubmed: 27993558
Ann Intern Med. 2017 Apr 4;166(7):514-530
pubmed: 28192789
Ann Intern Med. 2010 Jan 19;152(2):85-92
pubmed: 20083827
Subst Abus. 2019;40(4):396-404
pubmed: 31774388
Eval Health Prof. 2020 Sep 3;:163278720954229
pubmed: 32878456
Ann Intern Med. 2019 Apr 2;170(7):504-505
pubmed: 30557442
JAMA. 2011 Apr 6;305(13):1315-21
pubmed: 21467284
JAMA Psychiatry. 2019 Feb 1;76(2):208-216
pubmed: 30516809
Subst Abus. 2019;40(4):392-395
pubmed: 31746698
BMJ Open. 2019 Sep 20;9(9):e028633
pubmed: 31542740
Eur Spine J. 2018 Sep;27(Suppl 6):851-860
pubmed: 29460009
Ann Intern Med. 2018 Dec 18;169(12):892-894
pubmed: 30208400
J Rheumatol. 2021 May;48(5):775-784
pubmed: 33004531
Front Pharmacol. 2020 Nov 18;11:564412
pubmed: 33364942
Physiother Theory Pract. 2020 Aug;36(8):886-898
pubmed: 30265840
Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):93-9
pubmed: 18291290
Phys Ther. 2020 Jun 23;100(6):995-1007
pubmed: 32115638
N Engl J Med. 2017 Jul 27;377(4):391-394
pubmed: 28564549
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Subst Abus. 2019;40(4):435-440
pubmed: 31746677